70 HYPERPARATHYROIDISM AND THE CALCIUM PARADOX OF ALDOSTERONISM
PurposeIn congestive heart failure (CHF), aldosteronism may induce a syndrome that features oxi/nitrosative stress, a proinflammatory phenotype, soft tissue and bone wasting. We hypothesized aldosterone/1% NaCl treatment (ALDOST) in rats enhances urinary and fecal Ca2+ and Mg2+ excretion and leads t...
Gespeichert in:
Veröffentlicht in: | Journal of investigative medicine 2005-01, Vol.53 (1), p.S265-S266 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | S266 |
---|---|
container_issue | 1 |
container_start_page | S265 |
container_title | Journal of investigative medicine |
container_volume | 53 |
creator | Chhokar, V. S. Sun, Y. Bhattacharya, S. K. Ahokas, R. A. Myers, L. K. Xing, Z. Smith, R. A. Gerling, I. C. Weber, K. T. |
description | PurposeIn congestive heart failure (CHF), aldosteronism may induce a syndrome that features oxi/nitrosative stress, a proinflammatory phenotype, soft tissue and bone wasting. We hypothesized aldosterone/1% NaCl treatment (ALDOST) in rats enhances urinary and fecal Ca2+ and Mg2+ excretion and leads to systemic effects, including secondary hyperparathyroidism (SHPT).MethodsAt 1, 2, 4 and 6 weeks of ALDOST we monitored Ca2+ and Mg2+ excretion; ionized [Ca2+]o and [Mg2+]o, parathyroid hormone (PTH) and α1-antiproteinase activity (α1-AP) in plasma; bone mineral density (BMD) and bone strength (BS); total intracellular Ca2+ and Mg2+ in peripheral blood mononuclear cells (PBMC) and ventricular tissue; lymphocyte H2O2 production; and NADPH oxidase activation in ventricular tissue. A separate group received spironolactone (Spi), an aldosterone receptor antagonist. Age-/gender-matched unoperated and untreated rats served as controls.ResultsALDOST induced a marked (p < .05) and persistent rise (3-5 fold) in both 24 hour urinary and fecal Ca2+ and Mg2+ excretion at weeks 1-6, together with progressive reductions (p < .05) in plasma [Ca2+]o and [Mg2+]o, and elevation (p < .05) in PTH. A fall (P < .05) in BMD and BS was seen at weeks 4 and 6. An early, sustained increase (p < .05) in PBMC Ca2+ and Mg2+ and increase (p < .05) in ventricular tissue Ca2+ was seen at weeks 4 and 6 Plasma α1-AP activity was reduced (p < .05) while lymphocyte H2O2 production was increased (p < .05) at all time points and gp91phox-positive inflammatory cells invaded the perivascular space of intramural coronary arteries of both ventricles at weeks 4 and 6. Spi co-treatment attenuated (p < .05) urinary and fecal Ca2+ and Mg2+ excretion, prevented the fall in [Ca2+]o and [Mg2+]o, rescued BMD and BS, and prevented Ca2+ loading of PBMC and cardiomyocytes.ConclusionsAldosteronism promotes urinary and fecal Ca2+ and Mg2+ excretion leading to a fall in plasma ionized [Ca2+]o and [Mg2+]o with SHPT and bone resorption. PTH-mediated Ca2+ loading of PBMC and cardiac tissue induces oxi/nitrosative stress and results in a proinflammatory phenotype. SHPT accounts for this Ca2+ paradox and contributes to the pathophysiology of CHF with aldosteronism. This work was supported, in part, by NIH Training Grant GR HL07641 (to V.S.C.). |
doi_str_mv | 10.2310/6650.2005.00006.69 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1786935526</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4045623311</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1096-4ef30cd61d7807e3b46857a414561dffd31b1f6b38be76f3740f2b590db6101d3</originalsourceid><addsrcrecordid>eNqNkMFOwkAQhjdGExF9AU-beC7O7nZntyfT0GKbACWlJHLasLSbSESwhYNv71Z8AOcyf2a-fyb5CXlkMOKCwTOi9ApAjsAXjjC6IgOmQAeao7r2GjQLpNTRLbnruh0ARxnxAXlRQLP1Ii0XcRlX2bos8iRfzmg8T2iVpXQcT8f5akb7dVK80WJC42lSLKu0LOYevCc3bvPRNQ9_fUhWk7QaZ8G0eM29ObAMIgzCxgnY1shqpUE1woaopdqELJR-5lwtmGUOrdC2UeiECsFxKyOoLTJgtRiSp8vdY3v4OjfdyewO5_bTvzRMaYyElBw9xS_Utj10Xds4c2zf95v22zAwfVCmD8r0QZnfoIx3DklwMdn97j_8D_8_YE0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1786935526</pqid></control><display><type>article</type><title>70 HYPERPARATHYROIDISM AND THE CALCIUM PARADOX OF ALDOSTERONISM</title><source>SAGE Complete</source><creator>Chhokar, V. S. ; Sun, Y. ; Bhattacharya, S. K. ; Ahokas, R. A. ; Myers, L. K. ; Xing, Z. ; Smith, R. A. ; Gerling, I. C. ; Weber, K. T.</creator><creatorcontrib>Chhokar, V. S. ; Sun, Y. ; Bhattacharya, S. K. ; Ahokas, R. A. ; Myers, L. K. ; Xing, Z. ; Smith, R. A. ; Gerling, I. C. ; Weber, K. T.</creatorcontrib><description><![CDATA[PurposeIn congestive heart failure (CHF), aldosteronism may induce a syndrome that features oxi/nitrosative stress, a proinflammatory phenotype, soft tissue and bone wasting. We hypothesized aldosterone/1% NaCl treatment (ALDOST) in rats enhances urinary and fecal Ca2+ and Mg2+ excretion and leads to systemic effects, including secondary hyperparathyroidism (SHPT).MethodsAt 1, 2, 4 and 6 weeks of ALDOST we monitored Ca2+ and Mg2+ excretion; ionized [Ca2+]o and [Mg2+]o, parathyroid hormone (PTH) and α1-antiproteinase activity (α1-AP) in plasma; bone mineral density (BMD) and bone strength (BS); total intracellular Ca2+ and Mg2+ in peripheral blood mononuclear cells (PBMC) and ventricular tissue; lymphocyte H2O2 production; and NADPH oxidase activation in ventricular tissue. A separate group received spironolactone (Spi), an aldosterone receptor antagonist. Age-/gender-matched unoperated and untreated rats served as controls.ResultsALDOST induced a marked (p < .05) and persistent rise (3-5 fold) in both 24 hour urinary and fecal Ca2+ and Mg2+ excretion at weeks 1-6, together with progressive reductions (p < .05) in plasma [Ca2+]o and [Mg2+]o, and elevation (p < .05) in PTH. A fall (P < .05) in BMD and BS was seen at weeks 4 and 6. An early, sustained increase (p < .05) in PBMC Ca2+ and Mg2+ and increase (p < .05) in ventricular tissue Ca2+ was seen at weeks 4 and 6 Plasma α1-AP activity was reduced (p < .05) while lymphocyte H2O2 production was increased (p < .05) at all time points and gp91phox-positive inflammatory cells invaded the perivascular space of intramural coronary arteries of both ventricles at weeks 4 and 6. Spi co-treatment attenuated (p < .05) urinary and fecal Ca2+ and Mg2+ excretion, prevented the fall in [Ca2+]o and [Mg2+]o, rescued BMD and BS, and prevented Ca2+ loading of PBMC and cardiomyocytes.ConclusionsAldosteronism promotes urinary and fecal Ca2+ and Mg2+ excretion leading to a fall in plasma ionized [Ca2+]o and [Mg2+]o with SHPT and bone resorption. PTH-mediated Ca2+ loading of PBMC and cardiac tissue induces oxi/nitrosative stress and results in a proinflammatory phenotype. SHPT accounts for this Ca2+ paradox and contributes to the pathophysiology of CHF with aldosteronism. This work was supported, in part, by NIH Training Grant GR HL07641 (to V.S.C.).]]></description><identifier>ISSN: 1081-5589</identifier><identifier>EISSN: 1708-8267</identifier><identifier>DOI: 10.2310/6650.2005.00006.69</identifier><language>eng</language><publisher>London: Sage Publications Ltd</publisher><ispartof>Journal of investigative medicine, 2005-01, Vol.53 (1), p.S265-S266</ispartof><rights>2015 American Federation for Medical Research, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2015 (c) 2015 American Federation for Medical Research, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Chhokar, V. S.</creatorcontrib><creatorcontrib>Sun, Y.</creatorcontrib><creatorcontrib>Bhattacharya, S. K.</creatorcontrib><creatorcontrib>Ahokas, R. A.</creatorcontrib><creatorcontrib>Myers, L. K.</creatorcontrib><creatorcontrib>Xing, Z.</creatorcontrib><creatorcontrib>Smith, R. A.</creatorcontrib><creatorcontrib>Gerling, I. C.</creatorcontrib><creatorcontrib>Weber, K. T.</creatorcontrib><title>70 HYPERPARATHYROIDISM AND THE CALCIUM PARADOX OF ALDOSTERONISM</title><title>Journal of investigative medicine</title><description><![CDATA[PurposeIn congestive heart failure (CHF), aldosteronism may induce a syndrome that features oxi/nitrosative stress, a proinflammatory phenotype, soft tissue and bone wasting. We hypothesized aldosterone/1% NaCl treatment (ALDOST) in rats enhances urinary and fecal Ca2+ and Mg2+ excretion and leads to systemic effects, including secondary hyperparathyroidism (SHPT).MethodsAt 1, 2, 4 and 6 weeks of ALDOST we monitored Ca2+ and Mg2+ excretion; ionized [Ca2+]o and [Mg2+]o, parathyroid hormone (PTH) and α1-antiproteinase activity (α1-AP) in plasma; bone mineral density (BMD) and bone strength (BS); total intracellular Ca2+ and Mg2+ in peripheral blood mononuclear cells (PBMC) and ventricular tissue; lymphocyte H2O2 production; and NADPH oxidase activation in ventricular tissue. A separate group received spironolactone (Spi), an aldosterone receptor antagonist. Age-/gender-matched unoperated and untreated rats served as controls.ResultsALDOST induced a marked (p < .05) and persistent rise (3-5 fold) in both 24 hour urinary and fecal Ca2+ and Mg2+ excretion at weeks 1-6, together with progressive reductions (p < .05) in plasma [Ca2+]o and [Mg2+]o, and elevation (p < .05) in PTH. A fall (P < .05) in BMD and BS was seen at weeks 4 and 6. An early, sustained increase (p < .05) in PBMC Ca2+ and Mg2+ and increase (p < .05) in ventricular tissue Ca2+ was seen at weeks 4 and 6 Plasma α1-AP activity was reduced (p < .05) while lymphocyte H2O2 production was increased (p < .05) at all time points and gp91phox-positive inflammatory cells invaded the perivascular space of intramural coronary arteries of both ventricles at weeks 4 and 6. Spi co-treatment attenuated (p < .05) urinary and fecal Ca2+ and Mg2+ excretion, prevented the fall in [Ca2+]o and [Mg2+]o, rescued BMD and BS, and prevented Ca2+ loading of PBMC and cardiomyocytes.ConclusionsAldosteronism promotes urinary and fecal Ca2+ and Mg2+ excretion leading to a fall in plasma ionized [Ca2+]o and [Mg2+]o with SHPT and bone resorption. PTH-mediated Ca2+ loading of PBMC and cardiac tissue induces oxi/nitrosative stress and results in a proinflammatory phenotype. SHPT accounts for this Ca2+ paradox and contributes to the pathophysiology of CHF with aldosteronism. This work was supported, in part, by NIH Training Grant GR HL07641 (to V.S.C.).]]></description><issn>1081-5589</issn><issn>1708-8267</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNkMFOwkAQhjdGExF9AU-beC7O7nZntyfT0GKbACWlJHLasLSbSESwhYNv71Z8AOcyf2a-fyb5CXlkMOKCwTOi9ApAjsAXjjC6IgOmQAeao7r2GjQLpNTRLbnruh0ARxnxAXlRQLP1Ii0XcRlX2bos8iRfzmg8T2iVpXQcT8f5akb7dVK80WJC42lSLKu0LOYevCc3bvPRNQ9_fUhWk7QaZ8G0eM29ObAMIgzCxgnY1shqpUE1woaopdqELJR-5lwtmGUOrdC2UeiECsFxKyOoLTJgtRiSp8vdY3v4OjfdyewO5_bTvzRMaYyElBw9xS_Utj10Xds4c2zf95v22zAwfVCmD8r0QZnfoIx3DklwMdn97j_8D_8_YE0</recordid><startdate>200501</startdate><enddate>200501</enddate><creator>Chhokar, V. S.</creator><creator>Sun, Y.</creator><creator>Bhattacharya, S. K.</creator><creator>Ahokas, R. A.</creator><creator>Myers, L. K.</creator><creator>Xing, Z.</creator><creator>Smith, R. A.</creator><creator>Gerling, I. C.</creator><creator>Weber, K. T.</creator><general>Sage Publications Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AM</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGRYB</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K7.</scope><scope>K9.</scope><scope>M0O</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PRQQA</scope><scope>Q9U</scope></search><sort><creationdate>200501</creationdate><title>70 HYPERPARATHYROIDISM AND THE CALCIUM PARADOX OF ALDOSTERONISM</title><author>Chhokar, V. S. ; Sun, Y. ; Bhattacharya, S. K. ; Ahokas, R. A. ; Myers, L. K. ; Xing, Z. ; Smith, R. A. ; Gerling, I. C. ; Weber, K. T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1096-4ef30cd61d7807e3b46857a414561dffd31b1f6b38be76f3740f2b590db6101d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chhokar, V. S.</creatorcontrib><creatorcontrib>Sun, Y.</creatorcontrib><creatorcontrib>Bhattacharya, S. K.</creatorcontrib><creatorcontrib>Ahokas, R. A.</creatorcontrib><creatorcontrib>Myers, L. K.</creatorcontrib><creatorcontrib>Xing, Z.</creatorcontrib><creatorcontrib>Smith, R. A.</creatorcontrib><creatorcontrib>Gerling, I. C.</creatorcontrib><creatorcontrib>Weber, K. T.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Criminal Justice Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Criminology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Criminal Justice (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Criminal Justice</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Social Sciences</collection><collection>ProQuest Central Basic</collection><jtitle>Journal of investigative medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chhokar, V. S.</au><au>Sun, Y.</au><au>Bhattacharya, S. K.</au><au>Ahokas, R. A.</au><au>Myers, L. K.</au><au>Xing, Z.</au><au>Smith, R. A.</au><au>Gerling, I. C.</au><au>Weber, K. T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>70 HYPERPARATHYROIDISM AND THE CALCIUM PARADOX OF ALDOSTERONISM</atitle><jtitle>Journal of investigative medicine</jtitle><date>2005-01</date><risdate>2005</risdate><volume>53</volume><issue>1</issue><spage>S265</spage><epage>S266</epage><pages>S265-S266</pages><issn>1081-5589</issn><eissn>1708-8267</eissn><abstract><![CDATA[PurposeIn congestive heart failure (CHF), aldosteronism may induce a syndrome that features oxi/nitrosative stress, a proinflammatory phenotype, soft tissue and bone wasting. We hypothesized aldosterone/1% NaCl treatment (ALDOST) in rats enhances urinary and fecal Ca2+ and Mg2+ excretion and leads to systemic effects, including secondary hyperparathyroidism (SHPT).MethodsAt 1, 2, 4 and 6 weeks of ALDOST we monitored Ca2+ and Mg2+ excretion; ionized [Ca2+]o and [Mg2+]o, parathyroid hormone (PTH) and α1-antiproteinase activity (α1-AP) in plasma; bone mineral density (BMD) and bone strength (BS); total intracellular Ca2+ and Mg2+ in peripheral blood mononuclear cells (PBMC) and ventricular tissue; lymphocyte H2O2 production; and NADPH oxidase activation in ventricular tissue. A separate group received spironolactone (Spi), an aldosterone receptor antagonist. Age-/gender-matched unoperated and untreated rats served as controls.ResultsALDOST induced a marked (p < .05) and persistent rise (3-5 fold) in both 24 hour urinary and fecal Ca2+ and Mg2+ excretion at weeks 1-6, together with progressive reductions (p < .05) in plasma [Ca2+]o and [Mg2+]o, and elevation (p < .05) in PTH. A fall (P < .05) in BMD and BS was seen at weeks 4 and 6. An early, sustained increase (p < .05) in PBMC Ca2+ and Mg2+ and increase (p < .05) in ventricular tissue Ca2+ was seen at weeks 4 and 6 Plasma α1-AP activity was reduced (p < .05) while lymphocyte H2O2 production was increased (p < .05) at all time points and gp91phox-positive inflammatory cells invaded the perivascular space of intramural coronary arteries of both ventricles at weeks 4 and 6. Spi co-treatment attenuated (p < .05) urinary and fecal Ca2+ and Mg2+ excretion, prevented the fall in [Ca2+]o and [Mg2+]o, rescued BMD and BS, and prevented Ca2+ loading of PBMC and cardiomyocytes.ConclusionsAldosteronism promotes urinary and fecal Ca2+ and Mg2+ excretion leading to a fall in plasma ionized [Ca2+]o and [Mg2+]o with SHPT and bone resorption. PTH-mediated Ca2+ loading of PBMC and cardiac tissue induces oxi/nitrosative stress and results in a proinflammatory phenotype. SHPT accounts for this Ca2+ paradox and contributes to the pathophysiology of CHF with aldosteronism. This work was supported, in part, by NIH Training Grant GR HL07641 (to V.S.C.).]]></abstract><cop>London</cop><pub>Sage Publications Ltd</pub><doi>10.2310/6650.2005.00006.69</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1081-5589 |
ispartof | Journal of investigative medicine, 2005-01, Vol.53 (1), p.S265-S266 |
issn | 1081-5589 1708-8267 |
language | eng |
recordid | cdi_proquest_journals_1786935526 |
source | SAGE Complete |
title | 70 HYPERPARATHYROIDISM AND THE CALCIUM PARADOX OF ALDOSTERONISM |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T21%3A51%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=70%20HYPERPARATHYROIDISM%20AND%20THE%20CALCIUM%20PARADOX%20OF%20ALDOSTERONISM&rft.jtitle=Journal%20of%20investigative%20medicine&rft.au=Chhokar,%20V.%20S.&rft.date=2005-01&rft.volume=53&rft.issue=1&rft.spage=S265&rft.epage=S266&rft.pages=S265-S266&rft.issn=1081-5589&rft.eissn=1708-8267&rft_id=info:doi/10.2310/6650.2005.00006.69&rft_dat=%3Cproquest_cross%3E4045623311%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1786935526&rft_id=info:pmid/&rfr_iscdi=true |